Another inhibitory receptor, TIGIT (T-cell immunoglobulin and ITIM domain), which binds to the same ligands as DNAM-1, CD155, and CD112, has also been shown to be upregulated in AML blasts. This evidence concerns the gene PVR and acute myeloid leukemia.